A fatal case of hepatitis C seroconversion following living related kidney transplantation: Another argument for nucleic acid amplification testing of transplant recipients and donors

Transplant Infectious Disease

Volumn 4, Issue 2, 2002, Pages 113-114

  Gordon, S M ^a,b   Carey, W ^a   Yen Lieberman, B ^a   Dennis, V ^a   Nurko, S ^a   Hoeltge, G ^a   Goldfarb, D ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b Mailstop S 32 ^*  (United States)

Author keywords

Hepatitis C; Kidney transplantation; Nucleic acid amplification testing

Indexed keywords

ADULT; ANTIBODY DETECTION; CASE REPORT; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE COURSE; DONOR; EARLY DIAGNOSIS; FATALITY; FEMALE; HEPATITIS C; HUMAN; KIDNEY TRANSPLANTATION; LETTER; NUCLEIC ACID AMPLIFICATION; PRIORITY JOURNAL; SCREENING; SEROCONVERSION;

ADULT; ANTIVIRAL AGENTS; FATAL OUTCOME; FEMALE; HEPACIVIRUS; HEPATITIS C; HUMANS; KIDNEY TRANSPLANTATION; LIVING DONORS; RNA VIRUSES; VIREMIA;

EID: 0036618977     PISSN: 13982273     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-3062.2002.02001.x     Document Type: Letter

References (2)

1. Lee HH, Allain JP. Genomic screening for blood-borne viruses in transfusions settings. Vox Sang 1998: 74: 119-123.
2. Meng Q, Wong C, Rangachari A, et al. Automated multiplex assay system for simultaneous detection of hepatitis B virus DNA, hepatitis C virus RNA, and human immunodeficiency virus type 1 RNA. J Clin Microbiol 2001: 39: 2937-2945.